C131H144N23O22+ — CID 158168584
N-[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]acetamide;[2-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2-oxoethyl] acetate;[2-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2-oxoethyl]-trimethylazanium;N-[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]-2-(tert-butylamino)acetamide;N-[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]-2-(dimethylamino)acetamide (PubChem CID 158168584) has the molecular formula C131H144N23O22+ and a molecular weight of 2392.73 g/mol. Its IUPAC name is N-[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]acetamide;[2-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2-oxoethyl] acetate;[2-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2-oxoethyl]-trimethylazanium;N-[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]-2-(tert-butylamino)acetamide;N-[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]-2-(dimethylamino)acetamide.
| Compound Name | N-[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]acetamide;[2-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2-oxoethyl] acetate;[2-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2-oxoethyl]-trimethylazanium;N-[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]-2-(tert-butylamino)acetamide;N-[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]-2-(dimethylamino)acetamide |
|---|---|
| PubChem CID | 158168584 |
| Molecular Formula | C131H144N23O22+ |
| Molecular Weight | 2392.73 g/mol |
| Exact Mass | 2391.09 |
| IUPAC Name | N-[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]acetamide;[2-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2-oxoethyl] acetate;[2-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2-oxoethyl]-trimethylazanium;N-[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]-2-(tert-butylamino)acetamide;N-[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]-2-(dimethylamino)acetamide |
| SMILES | CC(=O)Nc1cccc2c(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)c[nH]c12.CC(=O)OCC(=O)Nc1cccc2c(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)c[nH]c12.C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2c(NC(=O)CN(C)C)cccc12.C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2c(NC(=O)CNC(C)(C)C)cccc12.C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2c(NC(=O)C[N+](C)(C)C)cccc12 |
| InChI | InChI=1S/C28H33N5O4.C27H31N5O4.C26H29N5O4.C26H26N4O6.C24H24N4O4/c1-18-17-32(26(36)19-9-6-5-7-10-19)13-14-33(18)27(37)25(35)21-15-29-24-20(21)11-8-12-22(24)31-23(34)16-30-28(2,3)4;1-18-16-30(26(35)19-9-6-5-7-10-19)13-14-31(18)27(36)25(34)21-15-28-24-20(21)11-8-12-22(24)29-23(33)17-32(2,3)4;1-17-15-30(25(34)18-8-5-4-6-9-18)12-13-31(17)26(35)24(33)20-14-27-23-19(20)10-7-11-21(23)28-22(32)16-29(2)3;1-16-14-29(25(34)18-7-4-3-5-8-18)11-12-30(16)26(35)24(33)20-13-27-23-19(20)9-6-10-21(23)28-22(32)15-36-17(2)31;1-15-14-27(23(31)17-7-4-3-5-8-17)11-12-28(15)24(32)22(30)19-13-25-21-18(19)9-6-10-20(21)26-16(2)29/h5-12,15,18,29-30H,13-14,16-17H2,1-4H3,(H,31,34);5-12,15,18H,13-14,16-17H2,1-4H3,(H-,28,29,33,34,36);4-11,14,17,27H,12-13,15-16H2,1-3H3,(H,28,32);3-10,13,16,27H,11-12,14-15H2,1-2H3,(H,28,32);3-10,13,15,25H,11-12,14H2,1-2H3,(H,26,29)/p+1/t2*18-;17-;16-;15-/m11111/s1 |
| InChIKey | FXDRPKJEAPLNLQ-HSOOXVHDSA-O |
| XLogP | 12.55 |
| TPSA | 554.47 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 28 |
| Heavy Atoms | 176 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2392.73 |
| LogP ≤ 5 | 12.55 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 24 |
| Structural Alerts | {'alert_name': 'diketo_group', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'} |
|---|